Literature DB >> 23159586

Brief smoking cessation intervention: a prospective trial in the urology setting.

Marc A Bjurlin1, Matthew R Cohn, Dae Y Kim, Vincent L Freeman, Lindsay Lombardo, Stephen D Hurley, Courtney M P Hollowell.   

Abstract

PURPOSE: Urologists have an important role in the treatment of tobacco related diseases, such as kidney and bladder cancer. Despite this role, urologists receive little training in promoting tobacco cessation. We prospectively evaluated a brief smoking cessation intervention offered by a urologist at an outpatient clinic.
MATERIALS AND METHODS: Between 2009 and 2011 adult smokers from a single institution urology clinic were enrolled in a prospective, brief intervention trial or in usual care as controls. All patients were assessed by the validated Fagerström test for nicotine dependence and the readiness to quit questionnaire. Trial patients received a 5-minute brief smoking cessation intervention. The primary outcome was abstinence at 1 year and the secondary outcome was the number of attempts to quit. Multivariate logistic regression was used to identify factors associated with the quit rate and quit attempts.
RESULTS: A total of 179 patients were enrolled in the study, including 100 in the brief smoking cessation intervention, 41 in the brief smoking cessation intervention plus nicotine replacement therapy and 38 usual care controls. Of the participants 81.0% were 40 years old or older with a mean ± SD 11.26 ± 7.23 pack-year smoking history. Mean readiness to quit and tobacco dependence scores were similar in the 2 arms (p = 0.25 and 0.92, respectively). The 1-year quit rate in the brief smoking cessation intervention group was 12.1% vs 2.6% in the usual care group (OR 4.44, p = 0.163) Adding nicotine replacement therapy increased the quit rate to 19.5% (vs usual care OR 9.91, p = 0.039). Patients who received the brief smoking cessation intervention were significantly more likely to attempt to quit (OR 2.31, p = 0.038). Increased readiness scores were associated with an increased quit rate and increased quit attempts.
CONCLUSIONS: Urologists can successfully implement a brief smoking cessation intervention program. Our study highlights the role of the urologist in providing smoking cessation assistance and the significant impact of brief, simple advice about quitting smoking on the smoker quit rate.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23159586     DOI: 10.1016/j.juro.2012.11.075

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer.

Authors:  Marilyn L Kwan; Brandon Garren; Matthew E Nielsen; Li Tang
Journal:  Urol Oncol       Date:  2018-04-25       Impact factor: 3.498

2.  The diagnosis of bladder cancer: are we missing a teachable moment for smoking cessation?

Authors:  Roman Sosnowski; Hubert Kamecki; Marc A Bjurlin; Krzysztof Przewoźniak
Journal:  Transl Androl Urol       Date:  2019-07

3.  Outcomes for a Public Hospital Tobacco Cessation Program: The Cook County Health and Hospitals System Experience.

Authors:  David N Goldberg; Anne J Krantz; Sara Semal; Huiyuan Zhang; William E Trick
Journal:  J Community Health       Date:  2016-12

4.  Effect of a Smoking Cessation Program on Sexual Function Recovery Following Robotic Prostatectomy at Kaiser Permanente Southern California.

Authors:  Seena Safavy; Patrick S Kilday; Jeff M Slezak; George A Abdelsayed; Teresa N Harrison; Steven J Jacobsen; Gary W Chien
Journal:  Perm J       Date:  2017

5.  Smoking-related genitourinary cancers: A global call to action in smoking cessation.

Authors:  Josh Gottlieb; Cory Higley; Roman Sosnowski; Marc A Bjurlin
Journal:  Rev Urol       Date:  2016

6.  Association of Biochemically Verified Post-Diagnosis Smoking and Nonmuscle-Invasive Bladder Cancer Recurrence Risk.

Authors:  Helena Furberg; Stacey Petruzella; Karissa Whiting; Emily Stein; Irene Orlow; Jessica Kenney; Sergio Corrales-Guerrero; Nicole Benfante; Eugene K Cha; Timothy F Donahue; Sherri M Donat; Harry W Herr; Richard S Matulewicz; Eugene Pietzak; Guido Dalbagni; Jamie Ostroff; Bernard H Bochner
Journal:  J Urol       Date:  2022-01-27       Impact factor: 7.600

7.  Knowledge of smoking as a risk factor for disease among urology clinic patients in Australia.

Authors:  Munad Khan; Nathan Papa; Todd Manning; Tatenda Nzenza; Lauren Simionato; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2018-03-27       Impact factor: 4.226

8.  Smoking and alcohol cessation intervention in relation to radical cystectomy: a qualitative study of cancer patients' experiences.

Authors:  Susanne Vahr Lauridsen; Thordis Thomsen; Gudrun Kaldan; Line Noes Lydom; Hanne Tønnesen
Journal:  BMC Cancer       Date:  2017-11-25       Impact factor: 4.430

9.  Role of cigarette smoking in urological malignancies and clinical interventions for smoking cessation.

Authors:  Roman Sosnowski; Marc A Bjurlin; Paolo Verze; Cosimo De Nunzio; Shahrokh F Shariat; Maurizio Brausi; Nicholas M Donin
Journal:  Cent European J Urol       Date:  2016-11-30

10.  The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.

Authors:  Frits H M van Osch; Sylvia H J Jochems; Raoul C Reulen; Sarah J Pirrie; Duncan Nekeman; Anke Wesselius; Nicholas D James; D Michael A Wallace; K K Cheng; Frederik J van Schooten; Richard T Bryan; Maurice P Zeegers
Journal:  Cancer Causes Control       Date:  2018-05-30       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.